1-1 of 1
Frederick Holtsberg, PhD
Close
Sort by
Journal Articles

KRX-101, a Novel FLT3 Inhibitor, Potently Active Against Resistant FLT3 -ITD/ FLT3 -TKD Mutant AML in Vitro and In Vivo

Herman O Sintim, PhD, M. Javad Aman, PhD, Frederick Holtsberg, PhD, Ashkan Emadi, MD PhD, Rena G Lapidus, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4049.
https://doi.org/10.1182/blood-2018-99-115260
Published: 2018